The drug delivery system constructed on the basis of albumin first crosses the barrier of vascular endothelial cells into the interstitial space of tumor tissues through the mediation of GP60, and then, drug carriers bind to SPARC expressed by tumor cells, ultimately achieving the goal of targeting tumor cells (Figure 3). The gene discussed is SPARC; the disease is neoplasm.